Background: The objective of the study was to evaluate the additional value of β-glucuronidase (BGD), a lysosomal enzyme in the analysis of transudative and exsudative pleural effusions, especially between malignant and non-malignant effusions. Design and methods: Pleural fluid samples obtained from four respective diagnostic groups: transudates parapneumonic effusions, malignant effusions or pleuritis carcinomatosa, and empyema were evaluated. Results: Beta-glucuronidase was significantly different between transudative and exsudative effusions (p < 0.001) as well as between parapneumonic and malignant effusions (p < 0.03), parapneumonic effusions and empyema (p < 0.002), and malignant and empyema (p < 0.002), respectively. Logistic regression analysis yielded a weak discrimination between the parapneumonic and malignant groups. Conclusions: Beta-glucuronidase activity differed between pleural effusions of various origin. However, including BGD in the biochemical work-up of pleural effusions did not reveal discriminatory value in the assessment of the classification of these effusions.

, ,
doi.org/10.1016/S0009-9120(99)00072-7, hdl.handle.net/1765/70484
Clinical Biochemistry
Erasmus MC: University Medical Center Rotterdam

Cobben, N., Drent, M., van Dieijen-Visser, M., Mulder, P., Wouters, E., & Henderson, R. (1999). Usefulness of monitoring β-glucuronidase in pleural effusions. Clinical Biochemistry, 32(8), 653–658. doi:10.1016/S0009-9120(99)00072-7